摘要
目的探究羊踯躅含药血清对肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)诱导的类风湿关节炎成纤维样滑膜细胞(rheumatoid arthritis fibroblast-like synoviocytes,RA-FLS)增殖和炎症因子分泌的影响和作用机制,为临床治疗RA提供理论及实验依据。方法将细胞分为空白组、模型组、雷公藤多苷组、5%和10%空白血清组及5%和10%羊踯躅含药血清组。RA-FLS经TNF-α(10 ng/mL)处理24 h以构建RA细胞模型。CCK-8检测细胞增殖情况。采用ELISA检测炎症因子白细胞介素-1β(interleukin-1 beta,IL-1β)、白细胞介素-17A(interleukin-17A,IL-17A)、白细胞介素-6(interleukin-6,IL-6)、白细胞介素-2(interleukin-2,IL-2)和γ干扰素(interferon-γ,IFN-γ)的含量。Western blot检测蛋白激酶B(protein kinase B,AKT1)、磷酸化AKT1(phosphorylated AKT1,p-AKT1)、原癌基因c-JUN、p-c-JUN、p65、p-p65、表皮生长因子受体(epidermal growth factor receptor,EGFR)蛋白表达水平。结果与未用羊踯躅含药血清处理的正常RA-FLS相比,用5%和10%羊踯躅含药血清处理的细胞增殖活性在48 h内没有明显的变化(P>0.05),而用20%和30%羊踯躅含药血清处理的细胞增殖活性明显降低(P<0.05)。与空白组相比,模型组的细胞增殖活性显著上升(P<0.05);与5%和10%空白血清组相比,5%和10%羊踯躅含药血清组的细胞增殖活性均显著降低(P<0.05)。与空白组相比,模型组的IL-1β、IL-17A、IL-6、IL-2和IFN-γ水平均明显升高(P<0.05);与5%和10%空白血清组相比,5%和10%羊踯躅含药血清组的IL-1β、IL-17A、IL-6、IL-2和IFN-γ水平明显下降(P<0.05)。与空白组相比,模型组的EGFR表达量以及AKT1、c-JUN和p65的磷酸化水平均明显升高(P<0.05);与5%和10%空白血清组相比,5%和10%羊踯躅含药血清组的EGFR表达量以及AKT1、c-JUN和p65的磷酸化水平显著降低(P<0.05)。此外,10%羊踯躅含药血清的效果比5%羊踯躅含药血清更为显著(P<0.05)。结论羊踯躅含药血清能抑制TNF-α诱导的RA-FLS增殖及促炎因子的分泌,其机制可能与调控EGFR、核因子-κB(nuclear factor-κB,NF-κB)、AKT和c-Jun N末端激酶(c-Jun N-terminal kinase,JNK)通路有关。
Objective To explore the effects and mechanism of action of medicated serum containing Rhododendron molle G.Don on the proliferation and inflammatory factors secretion of tumor necrosis factor-α(TNF-α)-induced rheumatoid arthritis fibroblast-like synoviocytes(RA-FLS),so as to provide theoretical and experimental basis for clinical treatment of RA.Methods RA-FLS cells were divided into blank group,model group,tripterygium glycosides group,blank serum(5%,10%)groups,and medicated serum(5%,10%)groups.RA-FLS were treated with TNF-α(10 ng/mL)for 24 h to construct RA cell models.Cell Counting Kit-8(CCK-8)was utilized to examine cell proliferation.Enzyme-linked immunosorbent assay(ELISA)was used to determine the content of inflammatory factors including interleukin-1 beta(IL-1β),interleukin-17A(IL-17A),interleukin-6(IL-6),interleukin-2(IL-2),and interferon-gamma(IFN-γ).Western blot was used to determine the protein expression levels of protein kinase B(AKT1),phosphorylated AKT1(p-AKT1),c-JUN,p-c-JUN,p65,p-p65,and epidermal growth factor receptor(EGFR).Results Compared with the groups without medicated serum containing Rhododendron molle G.Don,there was no significant change in cell proliferation activity within 48 h in the 5%and 10%medicated serum containing Rhododendron molle G.Don groups(P>0.05),but cell proliferation activity significantly reduced in the 20%and 30%medicated serum containing Rhododendron molle G.Don groups(P<0.05).Compared with the blank group,cell proliferation activity in the model group was significantly higher(P<0.05).Compared with the 5%and 10%blank serum groups,cell proliferation activity in the medicated serum groups containing different doses of Rhododendron molle G.Don was significantly lower(P<0.05).Compared with the blank group,the levels of IL-1β,IL-17A,IL-6,IL-2,and IFN-γin the model group were significantly higher(P<0.05).Compared with the blank serum groups,the levels of IL-1β,IL-17A,IL-6,IL-2,and IFN-γin the serum groups containing different doses of Rhododendron molle G.Don were significantly lower(P<0.05).Compared with the 5%and 10%blank group,the expression level of EGFR as well as the phosphorylation levels of AKT1,c-JUN,and p65 in the model group were significantly higher(P<0.05).Compared with the blank serum groups,the expression levels of EGFR as well as the phosphorylation levels of AKT1,c-JUN,and p65 in the medicated serum groups containing different doses of Rhododendron molle G.Don were significantly lower(P<0.05).Additionally,the effects of the 10%serum containing Rhododendron molle G.Don were more significant than those of the 5%medicated serum containing Rhododendron molle G.Don(P<0.05).Conclusion The medicated serum containing Rhododendron molle G.Don can inhibit cell proliferation and the secretion of pro-inflammatory factors of RA-FLS induced by TNF-α,which may be related to the regulation of EGFR,nuclear factorκB(NF-κB),AKT,and c-JUN N-terminal kinase(JNK)pathways.
作者
刘笑蓉
李硕夫
梅文亚
湛欢
刘平安
周日宝
LIU Xiaorong;LI Shuofu;MEI Wenya;ZHAN Huan;LIU Ping'an;ZHOU Ribao(Hunan University of Chinese Medicine,Changsha,Hunan 410208,China;The First Hospital of Hunan University of Chinese Medicine,Changsha,Hunan 410007,China;Hunan Academy of Chinese Medicine,Changsha,Hunan 410006,China)
出处
《湖南中医药大学学报》
CAS
2023年第10期1809-1814,共6页
Journal of Hunan University of Chinese Medicine
基金
湖南省自然科学基金项目(2022JJ80086)
湖南省卫健委科学研究项目(D202302078705)
湖南省教育厅科学研究项目(19C1384)
湖南省大学生创新创业训练计划项目(2022-5313)
湖南省中医药管理局科研计划项目(2021161)
湖南中医药大学中药学一级学科开放基金项目(2020ZYX01)
湖南中医药大学青苗计划(校行人字[2017]25)
湖南省一流学科中药学(校行科字[2018]3)
2020年湖南省一流本科专业建设点(湘教通[2020]248号):中药资源与开发2020年国家级一流本科专业建设点(教高厅函[2021]7号):中药学专业。
关键词
类风湿关节炎
成纤维样滑膜细胞
羊踯躅含药血清
细胞增殖
炎症因子
rheumatoid arthritis
fibroblast-like synoviocyte
medicated serum containing Rhododendron molle G.Don
cell proliferation
inflammatory factor
作者简介
第一作者:刘笑蓉,女,讲师,硕士,研究方向:中药资源与药效物质研究,E-mail:364059345@qq.com。